This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
5-APB: Difference between revisions
>Oskykins |
>Oskykins |
||
| Line 16: | Line 16: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | |||
5-APB is a triple reuptake inhibitor(TRI) with K<sub>i</sub> values of 180, 265 and 811 nM for NET, DAT and SERT respectively, as well as being an agonist for the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors (K<sub>i</sub> of 14nM at 5-HT<sub>2B</sub>). It has also been speculated from the structure activity relationship(SAR) that 5-APB is a monoamine releasing agent.<ref>https://en.wikipedia.org/wiki/5-APB</ref> | 5-APB is a triple reuptake inhibitor(TRI) with K<sub>i</sub> values of 180, 265 and 811 nM for NET, DAT and SERT respectively, as well as being an agonist for the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors (K<sub>i</sub> of 14nM at 5-HT<sub>2B</sub>). It has also been speculated from the structure activity relationship(SAR) that 5-APB is a monoamine releasing agent.<ref>https://en.wikipedia.org/wiki/5-APB</ref> | ||